Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Azzarone

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Blood|August 2, 2011
Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machineryMassimo Giuliani, Noufissa Oudrhiri, Zaeem M Noman, et al.
Bulletin Du Cancer|May 26, 2011
Interleukin-15 is a major regulator of the cell-microenvironment interactions in human renal cancerJulien Giron-Michel, Sandy Azzi, Krystel Khawam, et al.
International Journal of Cell Biology|July 31, 2019
Inhibition of TGF-<i>β</i>1 Signaling by IL-15: A Novel Role for IL-15 in the Control of Renal Epithelial-Mesenchymal Transition: IL-15 Counteracts TGF-<i>β</i>1-Induced EMT in Renal FibrosisAurore Devocelle, Lola Lecru, Hélène François, et al.
International Immunology|October 8, 2005
Lung myofibroblasts as targets of salmeterol and fluticasone propionate: inhibition of alpha-SMA and NF-kappaBSoria Baouz, Julien Giron-Michel, Bruno Azzarone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2004
CD40 on adult human airway epithelial cells: expression and proinflammatory effectsFrancesca Cagnoni, Susanna Oddera, Julien Giron-Michel, et al.
Blood|October 17, 2007
The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathwaysDaniela de Totero, Raffaella Meazza, Matteo Capaia, et al.
Blood|March 6, 2002
Leukemic target susceptibility to natural killer cytotoxicity: relationship with BCR-ABL expressionFrédéric Baron, Ali G Turhan, Julien Giron-Michel, et al.
Cancers|June 2, 2021
Pediatric Tumors-Mediated Inhibitory Effect on NK Cells: The Case of Neuroblastoma and Wilms' TumorsAndrea Pelosi, Piera Filomena Fiore, Sabina Di Matteo, et al.
Cancers|January 13, 2021
Wilms' Tumor Primary Cells Display Potent Immunoregulatory Properties on NK Cells and MacrophagesPiera Filomena Fiore, Paola Vacca, Nicola Tumino, et al.
Oncogene|October 31, 2003
Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cellsMichela Croce, Alessandro De Ambrosis, Maria V Corrias, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Blood|August 2, 2011
Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machineryMassimo Giuliani, Noufissa Oudrhiri, Zaeem M Noman, et al.
Bulletin Du Cancer|May 26, 2011
Interleukin-15 is a major regulator of the cell-microenvironment interactions in human renal cancerJulien Giron-Michel, Sandy Azzi, Krystel Khawam, et al.
International Journal of Cell Biology|July 31, 2019
Inhibition of TGF-<i>β</i>1 Signaling by IL-15: A Novel Role for IL-15 in the Control of Renal Epithelial-Mesenchymal Transition: IL-15 Counteracts TGF-<i>β</i>1-Induced EMT in Renal FibrosisAurore Devocelle, Lola Lecru, Hélène François, et al.
International Immunology|October 8, 2005
Lung myofibroblasts as targets of salmeterol and fluticasone propionate: inhibition of alpha-SMA and NF-kappaBSoria Baouz, Julien Giron-Michel, Bruno Azzarone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2004
CD40 on adult human airway epithelial cells: expression and proinflammatory effectsFrancesca Cagnoni, Susanna Oddera, Julien Giron-Michel, et al.
Blood|October 17, 2007
The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathwaysDaniela de Totero, Raffaella Meazza, Matteo Capaia, et al.
Blood|March 6, 2002
Leukemic target susceptibility to natural killer cytotoxicity: relationship with BCR-ABL expressionFrédéric Baron, Ali G Turhan, Julien Giron-Michel, et al.
Cancers|June 2, 2021
Pediatric Tumors-Mediated Inhibitory Effect on NK Cells: The Case of Neuroblastoma and Wilms' TumorsAndrea Pelosi, Piera Filomena Fiore, Sabina Di Matteo, et al.
Cancers|January 13, 2021
Wilms' Tumor Primary Cells Display Potent Immunoregulatory Properties on NK Cells and MacrophagesPiera Filomena Fiore, Paola Vacca, Nicola Tumino, et al.
Oncogene|October 31, 2003
Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cellsMichela Croce, Alessandro De Ambrosis, Maria V Corrias, et al.
Pageof 6